The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice
- PMID:33595957
- DOI: 10.1097/FBP.0000000000000626
The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice
Abstract
Psychedelic 5-hydroxytryptamine 2A receptor (5-HT2AR) agonists are showing promise in the treatment of psychiatric disorders, such as treatment-resistant depression and anxiety. Human studies suggest that enhanced cognitive flexibility may contribute to their clinical efficacy. Both improvement and impairment of cognitive flexibility has been reported with 5-HT2AR ligands, making the link between 5-HT2AR pharmacology and cognitive flexibility equivocal. We tested the selective 5-HT2AR agonist 25CN-NBOH in healthy male C57BL/6JOlaHsd mice in a touchscreen-based mouse reversal learning test. No effects were observed on acquisition of the new stimulus-reward contingency, learning errors, or perseverative responses during reversal. Our results suggest that 25CN-NBOH does not affect reversal learning in the schedule used in this study.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
- The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH.Jensen AA, Halberstadt AL, Märcher-Rørsted E, Odland AU, Chatha M, Speth N, Liebscher G, Hansen M, Bräuner-Osborne H, Palner M, Andreasen JT, Kristensen JL.Jensen AA, et al.Biochem Pharmacol. 2020 Jul;177:113979. doi: 10.1016/j.bcp.2020.113979. Epub 2020 Apr 13.Biochem Pharmacol. 2020.PMID:32298690
- Acute serotonin 2A receptor activation impairs behavioral flexibility in mice.Amodeo DA, Hassan O, Klein L, Halberstadt AL, Powell SB.Amodeo DA, et al.Behav Brain Res. 2020 Oct 1;395:112861. doi: 10.1016/j.bbr.2020.112861. Epub 2020 Aug 16.Behav Brain Res. 2020.PMID:32814148
- The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation.Odland AU, Jessen L, Kristensen JL, Fitzpatrick CM, Andreasen JT.Odland AU, et al.Neuropharmacology. 2021 Feb 1;183:107838. doi: 10.1016/j.neuropharm.2019.107838. Epub 2019 Nov 3.Neuropharmacology. 2021.PMID:31693871
- 25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor.Märcher Rørsted E, Jensen AA, Kristensen JL.Märcher Rørsted E, et al.ChemMedChem. 2021 Nov 5;16(21):3263-3270. doi: 10.1002/cmdc.202100395. Epub 2021 Aug 21.ChemMedChem. 2021.PMID:34288515Review.
- "Selective" serotonin 5-HT2A receptor antagonists.Casey AB, Cui M, Booth RG, Canal CE.Casey AB, et al.Biochem Pharmacol. 2022 Jun;200:115028. doi: 10.1016/j.bcp.2022.115028. Epub 2022 Apr 4.Biochem Pharmacol. 2022.PMID:35381208Free PMC article.Review.
Cited by
- Acute psilocybin enhances cognitive flexibility in rats.Torrado Pacheco A, Olson RJ, Garza G, Moghaddam B.Torrado Pacheco A, et al.bioRxiv [Preprint]. 2023 Jan 9:2023.01.09.523291. doi: 10.1101/2023.01.09.523291.bioRxiv. 2023.Update in:Neuropsychopharmacology. 2023 Jun;48(7):1011-1020. doi: 10.1038/s41386-023-01545-z.PMID:36712091Free PMC article.Updated.Preprint.
- Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms.Conn K, Milton LK, Huang K, Munguba H, Ruuska J, Lemus MB, Greaves E, Homman-Ludiye J, Oldfield BJ, Foldi CJ.Conn K, et al.Mol Psychiatry. 2024 Oct;29(10):3291-3304. doi: 10.1038/s41380-024-02575-9. Epub 2024 Apr 27.Mol Psychiatry. 2024.PMID:38678087Free PMC article.
- Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS.Doss MK, et al.Transl Psychiatry. 2021 Nov 8;11(1):574. doi: 10.1038/s41398-021-01706-y.Transl Psychiatry. 2021.PMID:34750350Free PMC article.
- Acute psilocybin enhances cognitive flexibility in rats.Torrado Pacheco A, Olson RJ, Garza G, Moghaddam B.Torrado Pacheco A, et al.Neuropsychopharmacology. 2023 Jun;48(7):1011-1020. doi: 10.1038/s41386-023-01545-z. Epub 2023 Feb 20.Neuropsychopharmacology. 2023.PMID:36807609Free PMC article.
- Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility.Šabanović M, Lazari A, Blanco-Pozo M, Tisca C, Tachrount M, Martins-Bach AB, Lerch JP, Walton ME, Bannerman DM.Šabanović M, et al.Mol Psychiatry. 2024 Jun;29(6):1810-1823. doi: 10.1038/s41380-024-02439-2. Epub 2024 Feb 7.Mol Psychiatry. 2024.PMID:38321122Free PMC article.
References
- Amodeo DA, Hassan O, Klein L, Halberstadt AL, Powell SB. (2020). Acute serotonin 2A receptor activation impairs behavioral flexibility in mice. Behav Brain Res. 395:112861.
- Amodeo DA, Jones JH, Sweeney JA, Ragozzino ME. (2014). Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice. Autism Res. 7:555–567.
- Araújo AM, Carvalho F, Bastos M d e L, Guedes de Pinho P, Carvalho M. (2015). The hallucinogenic world of tryptamines: an updated review. Arch Toxicol. 89:1151–1173.
- Bissonette GB, Powell EM. (2012). Reversal learning and attentional set-shifting in mice. Neuropharmacology. 62:1168–1174.
- Boulougouris V, Glennon JC, Robbins TW. (2008). Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats. Neuropsychopharmacology. 33:2007–2019.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources